Average weight loss depends on the dose, treatment length, and whether the patient also has type 2 diabetes
These conditions respond poorly to rest alone because the underlying tissue quality has deteriorated
A., Wei, W., Irannejad, R
It's just less invasive, less daunting
In addition, preclinical studies have suggested that the peptide may have benefits related to its ability to boost both GH and its anabolic mediator insulin-like growth factor-1 (IGF-1)
Unlike older weight loss medications that target one pathway, Retatrutide activates three different hormone receptors involved in appetite regulation and metabolism: GLP-1 receptor GIP receptor Glucagon receptor By targeting all three pathways simultaneously, researchers hope to create stronger effects on weight loss and metabolic health than previous medications